STALEY CAPITAL ADVISERS’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-905,366
| Closed | -$72.2M | – | 185 |
|
|
2024
Q1 | $72.2M | Sell |
905,366
-1,570
| -0.2% | -$120K | 3.37% | 8 |
|
|
2023
Q4 | $71.6M | Buy |
906,936
+17,854
| +2% | +$1.27M | 3.56% | 7 |
|
|
2023
Q3 | $62.1M | Buy |
889,082
+16,731
| +2% | +$1.19M | 3.42% | 8 |
|
|
2023
Q2 | $60.3M | Buy |
872,351
+38,160
| +5% | +$2.72M | 3.25% | 7 |
|
|
2023
Q1 | $62M | Buy |
834,191
+25,140
| +3% | +$2.11M | 3.47% | 7 |
|
|
2022
Q4 | $75.4M | Sell |
809,051
-737
| -0.1% | -$71.1K | 4.5% | 4 |
|
|
2022
Q3 | $77.2M | Sell |
809,788
-3,561
| -0.4% | -$352K | 4.93% | 4 |
|
|
2022
Q2 | $75.4M | Sell |
813,349
-374
| -0% | -$36.5K | 4.46% | 4 |
|
|
2022
Q1 | $82.4M | Sell |
813,723
-34,404
| -4% | -$3.61M | 4.16% | 5 |
|
|
2021
Q4 | $87.5M | Sell |
848,127
-28,500
| -3% | -$2.63M | 4.18% | 5 |
|
|
2021
Q3 | $74.4M | Sell |
876,627
-3,760
| -0.4% | -$315K | 3.99% | 6 |
|
|
2021
Q2 | $73.5M | Sell |
880,387
-90
| -0% | -$7.37K | 3.84% | 5 |
|
|
2021
Q1 | $66.2M | Buy |
880,477
+23,725
| +3% | +$1.73M | 3.68% | 6 |
|
|
2020
Q4 | $58.5M | Sell |
856,752
-6,499
| -0.8% | -$423K | 3.58% | 5 |
|
|
2020
Q3 | $50.4M | Buy |
863,251
+13,951
| +2% | +$868K | 3.49% | 5 |
|
|
2020
Q2 | $55.2M | Sell |
849,300
-9,452
| -1% | -$595K | 4% | 4 |
|
|
2020
Q1 | $51M | Buy |
858,752
+19,158
| +2% | +$1.28M | 4.28% | 4 |
|
|
2019
Q4 | $62.4M | Sell |
839,594
-6,097
| -0.7% | -$428K | 4.23% | 5 |
|
|
2019
Q3 | $53.3M | Buy |
845,691
+14,596
| +2% | +$865K | 4% | 5 |
|
|
2019
Q2 | $45.3M | Buy |
831,095
+16,036
| +2% | +$864K | 3.38% | 9 |
|
|
2019
Q1 | $44M | Buy |
815,059
+136,265
| +20% | +$8.41M | 3.25% | 11 |
|
|
2018
Q4 | $44.5M | Sell |
678,794
-15,321
| -2% | -$1.14M | 3.6% | 7 |
|
|
2018
Q3 | $54.6M | Sell |
694,115
-6,650
| -0.9% | -$475K | 3.82% | 4 |
|
|
2018
Q2 | $45.1M | Buy |
700,765
+27,545
| +4% | +$1.82M | 3.46% | 8 |
|
|
2018
Q1 | $41.9M | Buy |
673,220
+78,960
| +13% | +$5.67M | 3.29% | 9 |
|
|
2017
Q4 | $43.1M | Buy |
594,260
+20,200
| +4% | +$1.47M | 3.34% | 9 |
|
|
2017
Q3 | $46.7M | Buy |
574,060
+9,160
| +2% | +$725K | 3.81% | 6 |
|
|
2017
Q2 | $45.5M | Buy |
564,900
+19,340
| +4% | +$1.53M | 3.87% | 5 |
|
|
2017
Q1 | $42.8M | Buy |
545,560
+69,460
| +15% | +$5.55M | 3.83% | 6 |
|
|
2016
Q4 | $37.6M | Buy |
476,100
+98,010
| +26% | +$7.93M | 3.61% | 7 |
|
|
2016
Q3 | $33.6M | Buy |
378,090
+14,735
| +4% | +$1.39M | 3.36% | 8 |
|
|
2016
Q2 | $34.8M | Buy |
363,355
+315
| +0.1% | +$31.4K | 3.64% | 6 |
|
|
2016
Q1 | $37.7M | Buy |
363,040
+12,975
| +4% | +$1.26M | 4.07% | 4 |
|
|
2015
Q4 | $34.2M | Buy |
350,065
+22,680
| +7% | +$2.22M | 3.95% | 5 |
|
|
2015
Q3 | $31.6M | Buy |
327,385
+35,000
| +12% | +$3.68M | 3.84% | 5 |
|
|
2015
Q2 | $30.7M | Sell |
292,385
-250
| -0.1% | -$25.5K | 3.42% | 6 |
|
|
2015
Q1 | $30.2M | Sell |
292,635
-5,000
| -2% | -$506K | 3.48% | 4 |
|
|
2014
Q4 | $28.7M | Sell |
297,635
-20,579
| -6% | -$1.81M | 3.33% | 6 |
|
|
2014
Q3 | $25.3M | Buy |
318,214
+130
| +0% | +$10.2K | 3.02% | 7 |
|
|
2014
Q2 | $24M | Sell |
318,084
-2,070
| -0.6% | -$156K | 2.87% | 9 |
|
|
2014
Q1 | $24M | Buy |
320,154
+174
| +0.1% | +$12.3K | 3.04% | 7 |
|
|
2013
Q4 | $22.9M | Sell |
319,980
-7,790
| -2% | -$501K | 3.12% | 8 |
|
|
2013
Q3 | $18.6M | Sell |
327,770
-830
| -0.3% | -$49.5K | 2.83% | 11 |
|
|
2013
Q2 | $18.8M | Buy |
+328,600
| New | +$19M | 3.04% | 7 |
|
Other funds holding CVS
STALEY CAPITAL ADVISERS's CVS Position: Q2 2024 in Review
STALEY CAPITAL ADVISERS sold out of CVS Health (CVS) in Q2 2024, closing a stake of 905,366 shares — an estimated $72.2M sold.
STALEY CAPITAL ADVISERS first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $87.5M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- STALEY CAPITAL ADVISERS reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- STALEY CAPITAL ADVISERS sold 905,366 CVS Health shares in Q2 2024, an estimated $72.2M.
- STALEY CAPITAL ADVISERS first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
- STALEY CAPITAL ADVISERS's CVS Health position peaked at $87.5M in Q4 2021.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2024, filed 13 Aug 2024.